RFP Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25
Closed -$2.83K 299
2024
Q2
$2.83K Buy
25
+10
+67% +$1.26K ﹤0.01% 658
2024
Q1
$2.08K Buy
+15
New +$1.89K ﹤0.01% 668
2023
Q4
Sell
-44
Closed -$4.11K 917
2023
Q3
$4.11K Hold
44
﹤0.01% 543
2023
Q2
$5.65K Hold
44
﹤0.01% 530
2023
Q1
$5.11K Hold
44
0.01% 390
2022
Q4
$4.98K Buy
+44
New +$4.83K ﹤0.01% 523

Other funds holding DXCM

RFP Financial Group's DXCM Position: Q3 2024 in Review

RFP Financial Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 25 shares — an estimated $2.83K sold.

RFP Financial Group first reported a position in DXCM in Q4 2022 and held it in 6 quarters. The position peaked at $5.65K in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • RFP Financial Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 25 DexCom shares in Q3 2024, an estimated $2.83K.
  • RFP Financial Group first reported a position in DexCom in Q4 2022 and held it in 6 quarters.
  • RFP Financial Group's DexCom position peaked at $5.65K in Q2 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.